US Patent Issued to Akeso Biopharma on July 14 for "Anti-interleukin-17A antibody, pharmaceutical composition thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,887, issued on July 14, was assigned to Akeso Biopharma Inc. (Zhongshan, China).

"Anti-interleukin-17A antibody, pharmaceutical composition thereof and use thereof" was invented by Baiyong Li (Zhongshan, China), Yu Xia (Zhongshan, China), Zhongmin Maxwell Wang (Zhongshan, China) and Peng Zhang (Zhongshan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the fields of treating autoimmune diseases and molecular immunology, and specifically, to an anti-IL-17A antibody, a pharmaceutical composition thereof, and use thereof. The present invention relates to a monoclonal antibody or an antigen binding fragment thereof,...